ReviewFrontiers in immunology2023

Preclinical studies performed in appropriate models could help identify optimal timing of combined chemotherapy and immunotherapy.

Yani Berckmans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.